Cognitive Health

Sixty per cent of the human brain consists of fat, polyunsaturated fatty acids such as DHA in particular. DHA is essential to brain functions, but it is also essential for the prevention of brain cell damage. Poor memory, and particularly dementia such as Alzheimer’s disease, is associated with low concentrations of brain DHA. People with a regular intake of seafood have a lower risk of developing dementia.

In a clinical study of Alzheimer patients, it was shown that EPAX 1050 TG reduced memory decline in patients with an early stage of the disease. EPAX 1050 TG, which has a high concentration of DHA, provides nutritional support against age-related memory decline.

Click here to see articles about Omega-3 and Cognitive Health
 
 

EPAX 1050 TG

60 mg/g EPA
430 mg/g DHA

EPAX 1050 TG Specification
 EPAX 1050 TG Nutritional values

 

 
 
EPAX News & Events

Epax phase-3 study builds base for continued expansion into pharmaceutical omega-3 segment

Epax AS continues expansion into the pharmaceutical omega-3 segment with study
on AKR963 successfully achieving phase 3 study efficacy endpoints.

Read Press Release

 
 

EPAX Announces Corporate Restructuring

The Omega-3 lipids corporation previously formed by Trygg Pharma and former EPAX AS will be named EPAX AS. Former EPAX AS will become Epax Norway AS, a fully owned subsidiary and the key operating company of the Epax group.

Read press release

 
 

EPAX again honored as top supplier by Banner Pharmacaps.

EPAX AS was recognized for on-time deliveries and high quality standards.

Read press release

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map    •    Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com